Search

Author/Creator Kazemi, Shirin

1. Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM). (4th November 2015)

Authors:
Lapointe, Réjean; Jamal, Rahima; van Kempen, Leon; Thebault, Pamela; Belanger, Karl; Friedmann, Jennifer; Ayoub, Jean-Pierre; Cocolakis, Eftihia; Kazemi, Shirin; Dionne, Jeanne; Lambert, Caroline; Le, Huy; Grange, Cecile; Cailhier, Jean-Francois; Spatz, Alan; Miller, Wilson
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM). Issue 2 (December 2015)

Authors:
Lapointe, Réjean; Jamal, Rahima; van Kempen, Leon; Thebault, Pamela; Belanger, Karl; Friedmann, Jennifer; Ayoub, Jean-Pierre; Cocolakis, Eftihia; Kazemi, Shirin; Dionne, Jeanne; Lambert, Caroline; Le, Huy; Grange, Cecile; Cailhier, Jean-Francois; Spatz, Alan; Miller, Wilson
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma. Issue 1 (21st November 2017)

Authors:
Jamal, Rahima; Lapointe, Réjean; Cocolakis, Eftihia; Thébault, Paméla; Kazemi, Shirin; Friedmann, Jennifer E.; Dionne, Jeanne; Cailhier, Jean-François; Bélanger, Karl; Ayoub, Jean-Pierre; Le, Huy; Lambert, Caroline; El-Hajjar, Jida; van Kempen, Léon C.; Spatz, Alan; Miller, Wilson H.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗